Patents by Inventor Ronald Alfred Laskey

Ronald Alfred Laskey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND KITS
    Publication number: 20220260588
    Abstract: The present invention relates to methods for detecting the presence of Mcm5 in a subject, the method comprising preparing a sample from said subject by exposing the sample to a lysis buffer and performing an assay to determine the concentration of Mcm5 by exposing the sample to a first monoclonal antibody and/or a second monoclonal antibody and measuring the amount of Mcm5 that binds to the first monoclonal antibody and/or the second monoclonal antibody. The invention further relates to kits that can be used in the methods.
    Type: Application
    Filed: December 21, 2021
    Publication date: August 18, 2022
    Applicant: ARQUER DIAGNOSTICS LIMITED
    Inventors: David Nicholas MILLER-JONES, Cheryl NYBERG, Ronald Alfred LASKEY, Kai STOEBER
  • Methods and kits
    Patent number: 11391744
    Abstract: The present invention relates to methods for detecting the presence of Mcm5 in a subject, the method comprising preparing a sample from said subject by exposing the sample to a lysis buffer and performing an assay to determine the concentration of Mcm5 by exposing the sample to a first monoclonal antibody and/or a second monoclonal antibody and measuring the amount of Mcm5 that binds to the first monoclonal antibody and/or the second monoclonal antibody. The invention further relates to kits that can be used in the methods.
    Type: Grant
    Filed: June 1, 2016
    Date of Patent: July 19, 2022
    Assignee: ARQUER DIAGNOSTIC LIMITED
    Inventors: David Nicholas Miller-Jones, Cheryl Nyberg, Ronald Alfred Laskey, Kai Stoeber
  • MONOCLONAL ANTIBODIES BINDING MCM5
    Publication number: 20210277142
    Abstract: The present invention relates to antibodies that bind to Mcm5. The invention further relates to compositions or kits comprising the antibodies, hybridomas capable of expressing the antibodies, polynucleotides, polypeptides and vectors coding for the antibodies and methods for making the antibodies.
    Type: Application
    Filed: February 11, 2021
    Publication date: September 9, 2021
    Applicant: ARQUER DIAGNOSTICS LTD
    Inventors: Ronald Alfred LASKEY, Kai STOEBER
  • Assay
    Patent number: 10267801
    Abstract: This disclosure relates to a diagnostic/prognostic assay for prostate cancer and including kits used in said assay.
    Type: Grant
    Filed: September 17, 2014
    Date of Patent: April 23, 2019
    Inventor: Ronald Alfred Laskey
  • METHODS AND KITS
    Publication number: 20190079102
    Abstract: The present invention relates to methods for detecting the presence of Mcm5 in a subject, the method comprising preparing a sample from said subject by exposing the sample to a lysis buffer and performing an assay to determine the concentration of Mcm5 by exposing the sample to a first monoclonal antibody and/or a second monoclonal antibody and measuring the amount of Mcm5 that binds to the first monoclonal antibody and/or the second monoclonal antibody. The invention further relates to kits that can be used in the methods.
    Type: Application
    Filed: June 1, 2016
    Publication date: March 14, 2019
    Inventors: David Nicholas MILLER-JONES, Cheryl NYBERG, Ronald Alfred LASKEY, Kai STOEBER
  • MONOCLONAL ANTIBODIES BINDING MCM5
    Publication number: 20180186892
    Abstract: The present invention relates to antibodies that bind to Mcm5. The invention further relates to compositions or kits comprising the antibodies, hybridomas capable of expressing the antibodies, polynucleotides, polypeptides and vectors coding for the antibodies and methods for making the antibodies.
    Type: Application
    Filed: June 1, 2016
    Publication date: July 5, 2018
    Inventors: Ronald Alfred LASKEY, Kai STOEBER
  • ASSAY
    Publication number: 20150219659
    Abstract: This disclosure relates to a diagnostic/prognostic assay for prostate cancer and including kits used in said assay.
    Type: Application
    Filed: September 17, 2014
    Publication date: August 6, 2015
    Applicant: Cytosystems Limited
    Inventor: Ronald Alfred LASKEY
  • ASSAY
    Publication number: 20130171662
    Abstract: This disclosure relates to a diagnostic/prognostic assay for prostate cancer and including kits used in said assay.
    Type: Application
    Filed: December 15, 2010
    Publication date: July 4, 2013
    Applicant: Cytosystems Limited
    Inventor: Ronald Alfred Laskey
  • Cell-free system for initiation of DNA replication
    Patent number: 6107042
    Abstract: A cell-free system for initiating DNA replication under cell cycle control includes S phase cytosol or a fraction thereof in which are incubated G1 phase nuclei, which are co-incubated with S phase nuclei or a fraction thereof and/or cyclins A and/or E complexed to their cognate cyclin dependent kinase (Cdk2). The system may be used to assay for substances which modulate DNA synthesis or initiation thereof, and which have therapeutic potential in a number of contexts.
    Type: Grant
    Filed: January 25, 1999
    Date of Patent: August 22, 2000
    Assignee: Cancer Research Campaign Technology Limited
    Inventors: Ronald Alfred Laskey, Torsten Krude, Mark Richard Jackman, Jonathan Noe Joseph Pines